Trial intelligence / Profile preview

AEB071 vs Cyclosporine in Renal Transplant

NCT00504543Phase 2Completed

Sponsor
Novartis
Start
Jul 2007
Primary completion
Apr 2011
Modality
Small Molecules
Countries
17
01

Overview

A Phase 2 trial of sotrastaurin in kidney transplant rejection, sponsored by Novartis. Started Jul 2007; status: completed.

02

Drugs

sotrastaurin
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT00504543.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00504543.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call